{{Rsnum
|rsid=3118570
|Gene=RXRA
|Chromosome=9
|position=134429009
|Orientation=minus
|GMAF=0.1566
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=RXRA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 66.2 | 33.8 | 0.0
| HCB | 66.7 | 31.1 | 2.2
| JPT | 60.0 | 31.1 | 8.9
| YRI | 98.4 | 1.6 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 66.7 | 31.1 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19374686
|Title=RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism
}}

{{PMID Auto
|PMID=21292633
|Title=Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients
|OA=1
}}
{{PMID Auto
|PMID=21292632
|Title=A strong case for personalized, targeted cancer prevention
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}